Tao Deyou, Pan Yihong, Lu Hongsheng, Zheng Song, Lin Hui, Fang Hongyan, Cao Feilin
Department of Oncological Surgery, Luqiao Hospital of Taizhou Enze Medical Group Luqiao, Zhejiang, China.
Departments of Gynecology, Taizhou Central Hospital of Taizhou Enze Medical Group Taizhou, China.
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5819-27. eCollection 2014.
B-myb belongs to the myb family of transcription factors that include A-myb and c-myb. While A-myb and c-myb are tissue-specific, B-myb is broadly expressed in rapidly dividing cells of developing adult mammals. Results of our study showed that increased B-myb expression of was associated with the progression of breast cancer and that B-myb protein levels were significantly elevated in matched metastases. High B-myb levels also predict shorter overall survival of breast cancer patients. Moreover, B-myb stimulated transcription of target genes that promoted entry into the S and M-phases of the cell cycle, cell proliferation, migration and invasion in breast cancer. Taken together, our results strongly demonstrated that B-myb had a critical role in both cell cycle progression and tumorigenesis, and might serve as a novel potential target in the diagnosis and/or treatment of human breast cancer.
B-myb属于转录因子的myb家族,该家族包括A-myb和c-myb。虽然A-myb和c-myb具有组织特异性,但B-myb在成年哺乳动物发育过程中快速分裂的细胞中广泛表达。我们的研究结果表明,B-myb表达增加与乳腺癌进展相关,且在配对的转移灶中B-myb蛋白水平显著升高。高B-myb水平还预示着乳腺癌患者的总生存期较短。此外,B-myb刺激靶基因转录,促进进入细胞周期的S期和M期、细胞增殖、迁移及侵袭。综上所述,我们的结果有力地证明,B-myb在细胞周期进程和肿瘤发生中均起关键作用,可能成为人类乳腺癌诊断和/或治疗的新潜在靶点。